Clinical Outcomes and Economic Impact of Oritavancin for Gram-Positive Infections: A Single Academic Medical Center Health System Experience

• Main Authors: Lauren E. Brownell (Author), Meagan L. Adamsick (Author), Erin K. McCreary (Author), Joshua P. Vanderloo (Author), Erika J. Ernst (Author), Emily R. Jackson (Author), Lucas T Schulz (Author)
• Format: Book
• Published: Adis, Springer Healthcare, 2020-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Vancomycin treatment of complicated Gram-positive infections is associated with laboratory monitoring, nephrotoxicity, and multiple daily dosing. Oritavancin, a lipoglycopeptide antibiotic with a once-weekly dosing strategy and similar but slightly broader spectrum of activity, p...